• How an Unproven Alzheimer's Drug Got Approved

    2 monthes ago - By New York Times

    Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen's Aduhelm, or aducanumab.
    Read more ...